| Patents for A61P 13 - Drugs for disorders of the urinary system (56,135) |
|---|
| 06/21/2007 | CA2633093A1 Mglur1 antagonists as therapeutic agents |
| 06/20/2007 | EP1798229A1 Substituted biphenyl derivative |
| 06/20/2007 | EP1798221A1 2-arylcarboxamide-nitrogeneous heterocycle compound |
| 06/20/2007 | EP1797898A1 Preventive/therapeutic drug for arteriosclerosis |
| 06/20/2007 | EP1797878A2 Benzothiazole derivatives |
| 06/20/2007 | EP1797040A1 Muscarinic receptor antagonists |
| 06/20/2007 | EP1797033A2 20-cycloalkyl,26,27-alkyl/haloalkyl vitamin d3 compounds and methods of use thereof |
| 06/20/2007 | EP1796682A2 Method and composition for treating patients undergoing kidney dialysis |
| 06/20/2007 | EP1796643A1 Treatment of androgen - deprivation induced osteoporosis |
| 06/20/2007 | EP1796480A1 Fermented milk or vegetable proteins comprising receptor ligand and uses thereof |
| 06/20/2007 | EP1594517B1 Compositions for the treatment of gastrointestinal disorders |
| 06/20/2007 | EP1534256A4 Immunomodulation and effect on cell processes relating to serotonin family receptors and the blood-brain barrier |
| 06/20/2007 | EP1383762B1 Tetrahydropyridyl-alkyl-heterocycles, method for preparing same and pharmaceutical compositions containing same |
| 06/20/2007 | EP1381590B1 3,4-di-substituted cyclobutene-1,2-diones as cxc-chemokine receptor ligands |
| 06/20/2007 | EP1272204B1 Soft tissue and bone augmentation and bulking utilizing muscle-derived progenitor cells, compositions and treatments thereof |
| 06/20/2007 | CN1984900A Indole derivatives having piperidine rings |
| 06/20/2007 | CN1981856A Chinese medicine for treating and preventing early diabetes and nephropathy |
| 06/20/2007 | CN1981813A Guizhi Fuling solution solid dispersate |
| 06/20/2007 | CN1981806A Four-component prescription against urethral calculus |
| 06/20/2007 | CN1981786A Health-care medicinal liquor for tonifying kidney and Yang |
| 06/20/2007 | CN1981753A Medicine for controlling urine citric acid concentration and preventing nephrolithiasis |
| 06/20/2007 | CN1981745A Pharmaceutical formulations |
| 06/20/2007 | CN1322002C Methylene-4-azasteroids |
| 06/20/2007 | CN1321996C Process for preparing 2-iminopyrrolidine derivatives |
| 06/20/2007 | CN1321683C Use of neurotoxin therapy for treatment of urologic and related disorders |
| 06/20/2007 | CN1321676C Medicine for treating nephritis |
| 06/20/2007 | CN1321665C Combination of medication by using beartyberry and dragon's blood resin as combination of activities |
| 06/20/2007 | CN1321644C Process for making substituted pyrazoles |
| 06/20/2007 | CN1321634C Use of 6-dimethylaminomethy1-1-pheny1-cyclohexane compounds for treating urinary incontinence |
| 06/19/2007 | US7232906 Kinase inhibitors; antiinflammatory agents; respiratory system disorders; cardiovascular disorders; antidiabetic agents |
| 06/19/2007 | US7232821 (2-((2-alkoxy)-phenyl) -cyclopent-1enyl) aromatic carbo and heterocyclic acid and derivatives |
| 06/19/2007 | US7232814 Heterocyclic carboxy amines such as 9-nitro-7,12-dihydroindolo (3,2-d)(1)-benzazepin-6(5H)-one, used as inhibitors of glycogen synthase kinase-3 beta or cyclin dependent kinases |
| 06/19/2007 | CA2437468C Sensitization of chemotherapeutic agent resistant neoplastic cells with reovirus |
| 06/14/2007 | WO2007067581A1 2-(n-methyl-propanamine)-3-(2-naphthol) thiophene, an impurity of duloxetine hydrochloride |
| 06/14/2007 | WO2007066823A1 Antibody against connective tissue growth factor or composition containing the same |
| 06/14/2007 | WO2007066655A1 Equal-containing fermentation product of soybean embryonic axis, and method for production thereof |
| 06/14/2007 | WO2007066615A1 Novel activator of nuclear orphan receptor and use thereof |
| 06/14/2007 | WO2007066068A2 Calcium ion channel receptor antagonist |
| 06/14/2007 | US20070135409 Nonpeptide substituted spirobenzoazepines as vasopressin antagonists |
| 06/14/2007 | US20070135402 Azetidine ring compounds and drugs comprising the same |
| 06/14/2007 | US20070135386 Novel Compounds and Compositions as Cathepsin Inhibitors |
| 06/14/2007 | CA2631850A1 Equol-containing fermentation product of soybean embryonic axis, and method for production thereof |
| 06/13/2007 | EP1795203A2 Fhit proteins and nucleic acids and methods based thereon |
| 06/13/2007 | EP1795196A2 Method of treating lower urinary tract disorders |
| 06/13/2007 | EP1795192A2 1-Substituted imidazole derivatives as nos inhibitors |
| 06/13/2007 | EP1490065B1 Benzylimidazolyl substituted 2-quinolinone and quinazolinone derivatives for use as farnesyl transferase inhibitors |
| 06/13/2007 | EP1455810B1 Pharmaceutical formulation comprising cyclosporin and use thereof |
| 06/13/2007 | EP1416931B1 Inhibitors of polyq-aggregation |
| 06/13/2007 | EP1339737B1 Immunomodulatory protein derived from the yaba monkey tumor virus |
| 06/13/2007 | EP1337512B1 (4-acylaminopiperidin-1-yl) acetamides as neurokinin antagonists |
| 06/13/2007 | EP1140969B1 Connective tissue growth factor fragments and methods and uses thereof |
| 06/13/2007 | CN1977950A Chinese medicine composition for treating prostate disease |
| 06/13/2007 | CN1977834A New use of rosmarinic acid |
| 06/13/2007 | CN1321111C Crystal for oral solid drug and oral solid drug for dysuria treatment containing the same |
| 06/13/2007 | CN1320913C Medicine for treating toxuria |
| 06/13/2007 | CN1320907C Chinese traditional medicine for treating kidney disease and nephrotic syndrome and its preparation method |
| 06/13/2007 | CN1320884C Muscle strong agent and anti-inflammatory agent |
| 06/13/2007 | CN1320880C Improved formulation for topical non-invasive application in vivo |
| 06/12/2007 | US7230106 Process for the preparation of inhibitors of macrophage migration inhibitory factor |
| 06/12/2007 | US7230103 Substituted 3,4-dihydropyrido[1,2-a]pyrimidines |
| 06/12/2007 | US7230102 Derivatives of triazolyl-imidazopyridine and of the triazolylpurines useful as ligandsof the adenosine a2a receptor and their use as medicaments |
| 06/12/2007 | US7230030 Ether, alcohol, ester, carbamate or carbonate,sulfamate or silanol substituted-3,3-diphenylpropylamine derivatives; prodrugs of antimuscarinic agents with superior pharmacokinetic properties |
| 06/12/2007 | US7230026 Selected fused pyrrolocarbazoles |
| 06/12/2007 | US7230018 Substituted propane-1,3-diamine derivatives and the pharmaceutical use thereof |
| 06/12/2007 | US7230015 Potassium/sodium channel blockers; for treatment of multiple sclerosis, spinal cord injury, traumatic brain injury, stroke, bladder irritation and dysfunction, neuropathic pain and chemokine-induced pain |
| 06/12/2007 | US7229997 1-(pyridin-2-yl)-piperazine derivatives; serotonin receptor antagonists |
| 06/12/2007 | US7229987 Oxazoles with one or more tertiary amine groups and phenyl groups, e.g., 1-{4-[2-(Benzofuran-2-ylmethoxymethyl)-oxazol-5-yl]-phenyl}-3-(2-dimethylamino-ethyl)-urea and -(3-{4-[2-(2-Phenoxy-ethylsulfanylmethyl)-oxazol-5-yl]-phenoxy}-propyl)-azepine; treating obesity and related diseases, e.g., diabetes |
| 06/12/2007 | US7229755 Isolating a biological specimen from a human; testing the specimen for an alteration in a human MSH2 nucleotide sequence or its expression product; comparing the results obtained with the results obtained from a wild type control |
| 06/12/2007 | US7229646 Methods and compositions for modulating immune response and for the treatment of inflammatory disease |
| 06/12/2007 | US7229628 Blockade of T lymphocyte down-regulation associated with CTLA-4 signaling |
| 06/12/2007 | US7229623 Her-2/neu fusion proteins |
| 06/12/2007 | CA2198005C Pyrazolo[3,4-g]quinoxaline compounds which inhibit pdgf receptor protein tyrosine kinase |
| 06/07/2007 | WO2007063925A1 2-aminobenzamide derivative |
| 06/07/2007 | WO2007063822A1 Acid addition salt of dihydropyridine derivative |
| 06/07/2007 | WO2007063821A1 Acid addition salt of optically active dihydropyridine derivative |
| 06/07/2007 | WO2007043653A9 Benzimidazole-5-carboxamide derivative |
| 06/07/2007 | WO2007010281A3 Use of thiazole derivatives and analogues in disorders caused by free fatty acids |
| 06/07/2007 | US20070130629 Renal Regulatory Elements and Methods of Use Thereof |
| 06/07/2007 | US20070129420 New pyrrolidinium derivatives |
| 06/07/2007 | US20070129398 3(R)-1-Phenethyl-(9[H]-xanthene-9-carbonyloxy)-1-azoniabicyclo[2.2.2] octane quaternary salt with a mono- or polyvalent anion; antimuscarinic agents used to treat chronic obstructive pulmonary disease, chronic bronchitis, bronchial hyperreactivity, asthma, or rhinitis |
| 06/07/2007 | US20070129373 Phthalazinone-piperidino-derivatives as PDE4 inhibitors |
| 06/07/2007 | US20070129348 Receptor antagonist |
| 06/07/2007 | US20070129317 Use of boswellic acid and its derivatives for inhibiting normal and increased leucocytic elastase or plasmin activity |
| 06/07/2007 | US20070129316 antidepressant comprising at least one of scymnol or scymnol esters, soybean isoflavones and soybean isoflavone glycosides, curcumin, and or cholic acid; herbal medicine |
| 06/07/2007 | US20070128616 Aggrecanase molecules |
| 06/07/2007 | US20070128603 Diagnostic and therapeutics for diseases associated with 5-hydroxytryptamine (serotonin) receptor 7 (5-ht7) |
| 06/07/2007 | US20070128198 Compositions comprising antibodies to human fgl2 |
| 06/07/2007 | US20070128112 Fully human monoclonal antibodies that inhibit neovascularization of solid tumors; assaying for MCP-1; cancer diagnosis; may be conjugated to a chemotherapeutic agent such as taxol, doxorubicin, cis-platinum, and 5-fluorouracil. |
| 06/07/2007 | CA2631826A1 Acid addition salt of dihydropyridine derivative |
| 06/07/2007 | CA2631822A1 Acid addition salt of optically active dihydropyridine derivative |
| 06/07/2007 | CA2629964A1 2-aminobenzamide derivative |
| 06/06/2007 | EP1792989A1 13 Transmembrane protein expressed in prostate cancer |
| 06/06/2007 | EP1792898A1 Molecular chaperone function regulator |
| 06/06/2007 | EP1792629A1 Preventives/remedies for stress urinary incontinence and method of screening the same |
| 06/06/2007 | EP1792610A2 Sustained release bioadhesive therapeutic systems |
| 06/06/2007 | EP1791547A1 Oral formulations of paricalcitol |
| 06/06/2007 | EP1542666B1 Modafinil pharmaceutical compositions |
| 06/06/2007 | EP1489083B1 Fused bicyclic pyridine derivative as tachykinin receptor antagonist |
| 06/06/2007 | EP1406660B1 Combination of an aldosterone receptor antagonist and an hmg coa reductase inhibitor |
| 06/06/2007 | EP1158958B1 Improved powdery pharmaceutical compositions for inhalation |